|
Richard M. Goldberg M.D. is associate director of clinical research for the University of North Carolina's (UNC) Lineberger Comprehensive Cancer Center and physician-in-chief of the N.C. Cancer Hospital where he leads the continued development of an integrated comprehensive system for cancer care translational research multidisciplinary patient care and educational opportunities. He is also professor of medicine and chief of the division of hematology and oncology in the UNC School of Medicine's Department of Medicine. Before going to UNC in 2003 he was professor of oncology at the Mayo Clinic in Rochester Minn. where he chaired the Gastrointestinal Cancer Research Program. Currently he chairs the Gastrointestinal Cancer Committee for Cancer and Leukemia Group B a national clinical research group sponsored by the National Cancer Institute and is president of the International Society of Gastrointestinal Oncology. Dr. Goldberg is a member of the American Association for Cancer Research ASCO and the American Joint Commission on Cancer's colorectal task force. He has been an invited reviewer for many leading medical and oncology journals and the editorial boards of the NCI's Physician Data Query program and the Journal of Clinical Oncology and Oncology. His principal research interest is the evaluation of new agents for the treatment of colorectal cancer. He has coauthored more than 160 publications. Dr. Goldberg earned his M.D. from the Upstate Medical Center in Syracuse N.Y. | 